Abstract
Cutibacterium (Propionibacterium) acnes, considered a part of the skin microbiota, is one of the most commonly isolated anaerobic bacteria from medical implants in contact with plasma. However, the precise interaction of C. acnes with blood cells and plasma proteins has not been fully elucidated. Herein, we have investigated the molecular interaction of C. acnes with platelets and plasma proteins. We report that the ability of C. acnes to aggregate platelets is dependent on phylotype, with a significantly lower ability amongst type IB isolates, and the interaction of specific donor-dependent plasma proteins (or concentrations thereof) with C. acnes. Pretreatment of C. acnes with plasma reduces the lag time before aggregation demonstrating that pre-deposition of plasma proteins on C. acnes is an important step in platelet aggregation. Using mass spectrometry we identified several plasma proteins deposited on C. acnes, including IgG, fibrinogen and complement factors. Inhibition of IgG, fibrinogen or complement decreased C. acnes-mediated platelet aggregation, demonstrating the importance of these plasma proteins for aggregation. The interaction of C. acnes and platelets was visualized using fluorescence microscopy, verifying the presence of IgG and fibrinogen as components of the aggregates, and co-localization of C. acnes and platelets in the aggregates. Here, we have demonstrated the ability of C. acnes to activate and aggregate platelets in a bacterium and donor-specific fashion, as well as added mechanistic insights into this interaction.
Highlights
Propionibacterium acnes is a predominant skin bacterium that primarily colonizes sebum rich areas, and is suggested to benefit our health [1]
Using a skin isolate of C. acnes (AS12, phylotype II; [6]) we demonstrated that these bacteria can mediate platelet aggregation (Fig 1A)
Other studies have indicated that the bacterium:platelet ratio influences the ability of platelets to aggregate [23]
Summary
Propionibacterium acnes is a predominant skin bacterium that primarily colonizes sebum rich areas, and is suggested to benefit our health [1]. Due to its presence on skin, and its genetic diversity from several other Propionibacteria, it has been proposed to rename P. acnes to Cutibacterium acnes [2] and divide the different types into C. acnes subsp. Defendens (type II), and C. acnes subsp. Elongatum (type III) [3]. C. acnes is associated with several diseases, including acne [4], infective endocarditis (IE) [5] and localized chronic inflammation on medical implants due to biofilm formation [6]. C. acnes activates and aggregates platelets and analysis, decision to publish, or preparation of the manuscript
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.